SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The filing discloses the appointment of Akiko Moni Miyashita as a director of Averin Capital Acquisition Corp., effective May 28, 2026. The principal action is a person taking a board role, with detailed biographical information provided. As a SPAC director appointment, this is material to investors assessing the company's governance and business combination prospects.
View raw filing on EDGAR →The filing discloses a change in the registrant's independent accountant: PricewaterhouseCoopers LLP was dismissed and Ernst & Young LLP was engaged as the new independent registered public accounting firm, effective May 26, 2026. This is a textbook auditor change under Item 4.01. The disclosure includes the required confirmations that prior audit reports were unqualified and there were no disagreements or reportable events, which are standard representations in auditor-change filings.
View raw filing on EDGAR →CID HoldCo issued a senior secured convertible promissory note with a principal amount of $287,500 (cash proceeds of $230,000) to White Lion Capital, LLC on May 29, 2026, convertible into common stock at a variable conversion price of 80% of the lowest VWAP during a 15-day period. The unregistered issuance relies on Section 4(a)(2) and Regulation D exemptions and materially affects shareholder equity and voting power.
View raw filing on EDGAR →CEO Edmund Nabrotzky, CFO Charles Maddox, CTO Vijayan Nambiar, and CRO (Mrs. Rochester) have voluntarily agreed to reduce and defer their base salaries, with amendments to employment agreements and deferral agreements executed as part of cost-saving measures.
View raw filing on EDGAR →The company implemented a temporary employee furlough to preserve liquidity while evaluating financing opportunities, coupled with executive salary deferrals and explicit references in forward-looking statements to substantial doubt about the company's ability to continue as a going concern.
View raw filing on EDGAR →The 8-K discloses two press releases announcing "business developments" on May 20 and May 27, 2026, along with a "Pre-Paid Purchase" agreement with Streeterville Capital dated May 22, 2026. Without access to the actual press release content, the specific nature of these developments cannot be determined from the Item 8.01 disclosure alone. The reference to a pre-paid purchase agreement suggests potential financing or capital activity, but the exact materiality and event classification depend on the substance of the announcements, which are incorporated by reference but not detailed in the filing excerpt provided.
View raw filing on EDGAR →The filing announces the scheduling of an extraordinary general meeting on June 16, 2026, for Live Oak shareholders to vote on the "previously announced initial business combination transaction" with Teamshares Inc. The disclosure centers on the advancement of a material acquisition/merger—specifically, the announcement of the shareholder meeting date, effectiveness of the Registration Statement on Form S-4, and the Record Date. This is a critical milestone in the M&A process and directly material to investors assessing the registrant's strategic direction and capital structure.
View raw filing on EDGAR →Actinium Pharmaceuticals received a notice from NYSE American on May 27, 2026, indicating non-compliance with continued listing standards due to stockholders' equity of $2.3 million falling below the required $4.0 million threshold while reporting net losses in five consecutive fiscal years. The company must submit a compliance plan by June 26, 2026, or face delisting proceedings.
View raw filing on EDGAR →The company provided a material update on the development program for ATNM-400, a product candidate, disclosed via press release in connection with receipt of a Notice.
View raw filing on EDGAR →This is a Form 8-K Item 5.07 disclosure of shareholder vote results from the reconvened 2025 Annual Meeting of Stockholders held on May 29, 2026. The filing reports voting outcomes for three proposals: election of a Class I director (Arphing Lee), ratification of Bush & Associates CPA LLC as independent auditor, and approval of the 2025 Stock Incentive Plan. All three proposals passed, making this a material disclosure of shareholder actions that affects the composition of the board and approval of equity compensation arrangements.
View raw filing on EDGAR →Matternet completed an acquisition or disposition of assets, as disclosed under Item 2.01. This transaction materially affects the registrant's asset base and strategic direction.
View raw filing on EDGAR →Matternet experienced a change in control of the registrant, as disclosed under Item 5.01. This change-of-control event materially affects the registrant's governance and ownership structure.
View raw filing on EDGAR →Matternet completed an unregistered sale of equity securities, as disclosed under Item 3.02. This dilutive issuance materially affects ownership dilution and capital structure.
View raw filing on EDGAR →Matternet changed its independent accountant, as disclosed under Item 4.01. This auditor change is material to investors as it may signal underlying accounting or governance concerns.
View raw filing on EDGAR →Matternet entered into a material definitive agreement, as disclosed under Item 1.01. Without substantive details on the agreement's parties, terms, or business purpose, the specific event classification cannot be determined with confidence.
View raw filing on EDGAR →Matternet made a material modification to the rights of security holders, as disclosed under Item 3.03. The specific nature of the modification (e.g., charter amendment, voting rights change) cannot be determined from the item heading alone.
View raw filing on EDGAR →Matternet experienced a change in shell company status, as disclosed under Item 5.06. This change materially affects the registrant's regulatory classification and investor protections.
View raw filing on EDGAR →Ondas Inc. completed an unregistered sale of equity securities under Section 4(a)(2) and Regulation D, Rule 506 exemptions, representing a material private placement that affects shareholder dilution and the company's capital structure.
View raw filing on EDGAR →WisdomTree disclosed entry into privately negotiated repurchase agreements to buy back approximately $51.9 million in principal amount of its 3.25% Convertible Senior Notes due 2029 for $87.3 million in cash. This is a material capital allocation and debt reduction event that would affect investor assessment of the company's financial position and leverage, but it does not fit cleanly into the more specific event categories (not M&A, not a covenant breach, not a dilutive issuance). The transaction is material and disclosed under Item 8.01 as an "Other Event."
View raw filing on EDGAR →This Item 5.07 disclosure presents the complete results of The Mosaic Company's 2026 Annual Meeting of Stockholders, including voting tallies for director elections (all twelve directors elected), ratification of KPMG LLP as independent auditor, and advisory approval of executive compensation. The detailed vote counts for each matter are the core content of a shareholder_vote_results event.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Roblox's 2026 Annual Meeting of Stockholders held on May 28, 2026. The filing presents voting outcomes for three proposals: election of three directors (David Baszucki, Gregory Baszucki, and Dennis Durkin), advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. The detailed vote tallies (votes for, against, abstentions, and broker non-votes) are the core content of this Item 5.07 disclosure.
View raw filing on EDGAR →This Item 2.03 disclosure describes the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Des Moines, which are joint and several obligations of all eleven Federal Home Loan Banks. While the filing creates direct financial obligations through debt issuance, the prose emphasizes that the Bank has "not made a judgment as to the materiality of any particular consolidated obligation or obligations" and focuses on regulatory framework and reporting methodology rather than a specific material debt event. The disclosure is material to the Bank's operations but does not fit cleanly into the covenant_breach or other specific debt-related categories, as it describes routine consolidated obligation issuance mechanics rather than a triggering financial event.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Employers Holdings' 2026 annual meeting of stockholders held on May 28, 2026. The filing presents voting results for three matters: election of eight directors, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The detailed vote tallies (for, against, abstentions, broker non-votes) for each director and proposal are the core content of the filing, making this unambiguously a shareholder_vote_results event.
View raw filing on EDGAR →Tiptree completed the sale of Fortegra to an undisclosed Purchaser for $1.65 billion in cash (approximately $1.08 billion net to Tiptree after adjustments) on May 29, 2026. In connection with the merger closing, Tiptree entered into material credit facility amendments and consents (South Bay Consent and FFC Amendment) to obtain lender approval for the change of control and address going-concern qualifications, and terminated the Fortress Credit Agreement with repayment of all obligations.
View raw filing on EDGAR →This Item 5.07 filing discloses the final results of American Coastal Insurance's 2026 Annual Meeting of stockholders, including voting outcomes for two proposals: election of five Class B directors and ratification of Deloitte & Touche, LLP as independent auditor. The detailed vote tallies (For, Against, Abstained, Broker Non Votes) for each director and the auditor ratification are the core disclosure, making this a textbook shareholder_vote_results event that is material to investors assessing board composition and audit oversight.
View raw filing on EDGAR →AGNC Investment Corp. entered into "at the market" (ATM) sales agreements with 14 major financial institutions to offer and sell up to $2 billion in common stock. This is a classic dilutive equity issuance disclosed under Item 8.01, with the potential to significantly increase share count and dilute existing shareholders. The magnitude ($2 billion) and structure (ATM program with multiple agents) are material to investors assessing capital structure and shareholder value.
View raw filing on EDGAR →The disclosure announces new clinical data for Moleculin's lead drug candidate Annamycin presented at ASCO, highlighting a "differentiated cardiac safety profile." This is material clinical trial progress for a biotech company with a lead candidate in development, as it addresses a critical safety concern that could influence investor assessment of the drug's commercial viability and regulatory pathway. However, it does not fit neatly into earnings_release (no financial results), material_litigation, or other more specific categories, making other_material the most appropriate classification.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Broadwind's Annual Meeting of Stockholders held on May 28, 2026. The filing reports voting outcomes on three matters: (i) election of five directors, (ii) non-binding advisory vote on named executive officer compensation ("Say-on-Pay"), and (iii) ratification of RSM US LLP as independent auditor. All three votes passed with substantial majorities. This is a routine but material disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →The disclosure centers on a new employment agreement with CEO Michael Benstock entered into on May 26, 2026, detailing comprehensive compensatory arrangements including base salary ($1,044,399), guaranteed bonuses ($500,000 annually for 2026-2028), a $2,100,000 retention bonus, severance multiples (2.0x highest annual compensation), and equity acceleration provisions. While the agreement also addresses employment terms and conditions, the material substance is the negotiated compensation package and severance structure, which would materially affect investor assessment of executive costs and change-of-control obligations.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from HealthStream's May 28, 2026 annual meeting, covering three proposals: election of three Class II directors, ratification of Ernst & Young LLP as independent auditor, and approval of a non-binding say-on-pay resolution. The filing presents final vote tallies for each proposal, which is the quintessential content of Item 5.07 disclosures and materially informs investors about shareholder governance actions.
View raw filing on EDGAR →Monopar disclosed Phase 2 clinical trial results for ALXN1840 (tiomolibdate choline) in Wilson disease patients presented at a major medical conference (EASL 2026). While this represents material clinical progress for a therapeutic candidate, it does not fit neatly into the standard taxonomy categories (not an earnings release, M&A activity, executive change, or financial restatement). Clinical trial results presented at conferences are typically material to investors assessing pipeline value and development progress, warranting classification as other_material.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the final results of Coastal Financial's 2026 annual meeting of shareholders held on May 27, 2026. The filing presents voting results for three matters: election of directors (Delorier, Hovde, Patterson, Tisdel, and Chapman), ratification of Baker Tilly US, LLP as independent auditor, and an advisory vote on executive compensation. The detailed vote tallies (For/Against/Abstain/Broker Non-Votes) for each proposal are the core content of this disclosure, which is material to investors assessing corporate governance and board composition.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of SiTime Corporation's Annual Meeting of Stockholders held on May 29, 2026, with voting tallies for three proposals: election of three Class I directors (Torsten G. Kreindl, Ganesh Moorthy, and Akira Takata), advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. The detailed vote counts (For, Against/Withheld, Abstain, and Broker Non-Votes) for each proposal are the core disclosure, which is the defining characteristic of shareholder vote results under Item 5.07.
View raw filing on EDGAR →The filing discloses settlement of putative federal antitrust class action litigation (In re: PVC Pipe Antitrust Litigation) with two of three plaintiff classes, involving aggregate settlement payments of $73.5 million ($39.5 million to Direct Purchasers and $34.0 million to Non-Converter Seller Purchasers). This material litigation settlement would significantly affect a reasonable investor's assessment of the company's financial exposure and legal risk, even though the company does not admit wrongdoing.
View raw filing on EDGAR →The filing discloses receipt of a deficiency letter from Nasdaq on April 17, 2026, notifying Expensify that its Class A common stock had fallen below the $1.00 minimum bid price requirement for continued listing on The Nasdaq Global Select Market under Listing Rule 5450(a)(1). Although the Company subsequently regained compliance by May 28, 2026, the initial deficiency notice and the period of non-compliance constitute a material delisting risk event that would affect investor assessment of the registrant's listing status.
View raw filing on EDGAR →Classover Holdings sold $600,000 principal amount of senior secured convertible notes to an investor under a Securities Purchase Agreement amendment, with conversion rights into Class B common stock and an option for the buyer to purchase up to an additional $339 million in notes. The unregistered sale under Section 4(a)(2) and convertible structure constitute a material dilutive financing arrangement.
View raw filing on EDGAR →Classover Holdings, Inc. amended its certificate of incorporation to change its legal name to 'KIDZ AI Inc.' effective May 26, 2026. The corporate name change is a material event affecting investor identification and security trading.
View raw filing on EDGAR →Item 2.03 discloses creation of a direct financial obligation and incorporates by reference Item 1.01, indicating a material acquisition or merger with associated financing obligations underlying the convertible note transaction.
View raw filing on EDGAR →Edible Garden received a notice from Nasdaq on May 27, 2026 that it failed to maintain the minimum $1 bid price required under Nasdaq Listing Rule 5550(a)(2) for at least 30 consecutive business days. The company is ineligible for a compliance period due to prior reverse stock splits exceeding the 250:1 cumulative threshold, and its securities will be suspended from trading on June 5, 2026 unless it successfully appeals to a Nasdaq Hearings Panel by June 3, 2026. This is a clear delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →CEA Industries filed a complaint in U.S. District Court against 10X Capital LLC seeking to void an Asset Management Agreement as unconscionable and recover all fees paid since inception, or alternatively to invalidate a liquidated damages clause that would accelerate nearly 20 years of future fees. This is material litigation that directly affects the Company's financial obligations and contractual relationships, disclosed under Item 8.01 (Other Events).
View raw filing on EDGAR →LyondellBasell entered into an Eighth Amendment to its structured accounts receivable facility, extending the term to June 2027 and reducing the maximum available amount from $900 million to $700 million. This amendment materially affects the Company's liquidity and financing structure.
View raw filing on EDGAR →The filing discloses a change in the Company's independent accountant, with Fruci & Associates II, PLLC resigning on May 5, 2026 at the Company's request, and KAN Accounting Solutions pllc engaged as the replacement on May 27, 2026. This is a classic auditor change under Item 4.01, and the disclosure confirms no prior consultations with the new auditor regarding accounting principles or reportable events, consistent with standard auditor-change disclosure requirements.
View raw filing on EDGAR →The filing discloses the entry into and completion of a material acquisition: Nano Nuclear Energy Inc. acquired 100% of the membership interests of Secured Transportation Services LLC (STS) for up to $13.0 million in total consideration (cash, restricted shares, and deferred stock consideration). The transaction closed on May 22, 2026, and is disclosed under Items 1.01 (Entry Into a Material Definitive Agreement) and 2.01 (Completion of Acquisition or Disposition of Assets), with STS becoming a subsidiary of Nano. This is a material M&A event affecting the registrant's business and financial position.
View raw filing on EDGAR →The filing discloses two unregistered private placements of common stock totaling approximately 26.7 million shares (13.3 million each from Brown Stone Capital Ltd. and EEME Energy SPV I, LLC) at $0.15 per share for ~$4 million aggregate proceeds. The securities are issued under Section 4(a)(2) and Regulation D Rule 506(b), and Item 3.02 explicitly incorporates the unregistered sales disclosure. This is a material dilutive equity issuance typical of small-cap companies raising capital through private placements.
View raw filing on EDGAR →The filing discloses a press release announcing the launch of a 50+ physical qubit neutral-atom quantum computer with targets for thousands of qubits by end of H1 2027. This represents a significant product milestone and technological achievement for a quantum computing company, but does not fit neatly into standard 8-K event categories (not earnings, M&A, executive changes, impairment, litigation, or cybersecurity). The announcement is material to investors assessing the company's progress and competitive position in quantum computing, warranting disclosure under Item 8.01 (Other Events).
View raw filing on EDGAR →The filing discloses both the retirement of Anna T. Chew as CFO and the appointment of Kevin S. Miller as her successor, effective June 1, 2026. While both events occur, the principal action emphasized in the disclosure structure is Miller's appointment to the CFO role, with detailed background on his qualifications and compensation ($430,000 annual base). The retirement is presented as the context for the appointment rather than as the primary event. This is material as it involves a change in the Company's chief financial officer.
View raw filing on EDGAR →The filing discloses entry into a material definitive agreement under Item 1.01: an Option to Purchase Agreement for the Zermatt Resort in Midway, Utah, with a subsequent addendum extending the option period by 90 days. While the company has not yet completed the acquisition, the option agreement represents a material commitment to a potential real estate acquisition that would be significant to investors assessing the company's strategic direction and capital deployment.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from AtlasClear's May 27, 2026 annual meeting. The filing presents final voting tallies for three proposals: election of six directors, approval of a 15,000,000-share increase to the 2024 Equity Incentive Plan, and ratification of Haynie & Company as independent auditor. All three proposals passed with majority support, and the detailed vote counts (For/Against/Withheld/Abstentions/Broker Non-Votes) are the core substance of the disclosure.
View raw filing on EDGAR →The filing's primary substantive disclosure is Item 5.07, which reports the results of the 2026 Annual Meeting of Stockholders held on May 28, 2026. The filing details voting outcomes on six director elections, a say-on-pay proposal, a reverse stock split proposal, an authorized stock increase proposal, and auditor ratification. While Item 5.02 addresses new RSU and RSA award agreement forms (an executive compensation matter), the bulk of the 8-K content and materiality centers on the shareholder vote results, particularly the failed Authorized Stock Increase Proposal (427,158 for vs. 555,147 against), which would be material to investors assessing the company's capital structure flexibility.
View raw filing on EDGAR →The filing discloses compensatory arrangements for two named executives under Item 5.02(e): performance-based stock option grants to CEO Daniyel Erdberg (750,000 options) and CFO Theresa Carlise (150,000 options) with five-year vesting tied to revenue milestones, plus Amendment No. 4 to Ms. Carlise's employment agreement modifying her bonus structure, severance, and change-in-control provisions. These equity grants and employment modifications are material to investors' assessment of executive incentive alignment and retention costs.
View raw filing on EDGAR →